Key Takeaways Haemonetics sees growth led by Hospital recovery and strong NexSys PCS momentum. HAE's NexSys PCS gains from Persona rollout, higher yields and faster donor processing times. HAE's Hospital revenue rose 5% with solid Blood Management Technologies and Vascular Closure gains. Haemonetics Corporation’s (HAE) impressive Hospital business recovery is poised to drive growth in the upcoming quarters. The robust uptake of the NexSys PCS system bodes well for its long-term growth. However, a dull macr ...